Total Payments
$4,325
2024 Payments
$611.17
Companies
23
Transactions
196
Medicare Patients
687
Medicare Billing
$114,348
Payment Breakdown by Category
Food & Beverage$4,325 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,325 | 196 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $1,074 | 57 | $0 (2024) |
| ABBVIE INC. | $905.88 | 54 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $599.57 | 20 | $0 (2024) |
| Amgen Inc. | $350.42 | 7 | $0 (2021) |
| Biogen, Inc. | $188.59 | 13 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $175.39 | 7 | $0 (2021) |
| Neurelis, Inc. | $152.33 | 7 | $0 (2022) |
| Supernus Pharmaceuticals, Inc. | $152.15 | 7 | $0 (2021) |
| LivaNova USA, Inc. | $147.63 | 4 | $0 (2020) |
| Allergan, Inc. | $102.92 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $611.17 | 33 | ABBVIE INC. ($337.50) |
| 2023 | $695.71 | 31 | ABBVIE INC. ($241.81) |
| 2022 | $448.63 | 22 | UCB, Inc. ($265.09) |
| 2021 | $1,171 | 60 | AbbVie Inc. ($326.57) |
| 2020 | $768.37 | 31 | Amgen Inc. ($173.95) |
| 2019 | $629.87 | 19 | Alexion Pharmaceuticals, Inc. ($164.08) |
All Payment Transactions
196 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | UCB, Inc. | Zilbrysq (Drug) | Food and Beverage | In-kind items and services | $29.47 | General |
| Category: Neurology | ||||||
| 11/27/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/10/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $26.25 | General |
| Category: Rare Disease | ||||||
| 08/29/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $32.07 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/15/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: AMANTADINE | ||||||
| 07/30/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $31.41 | General |
| Category: Rare Disease | ||||||
| 07/24/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: Neurology | ||||||
| 06/25/2024 | BioMarin Pharmaceutical Inc. | Brineura (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: CLN 2 | ||||||
| 06/18/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: NEUROSCIENCE | ||||||
| 06/05/2024 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Immunology | ||||||
| 05/25/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $10.16 | General |
| Category: NEUROSCIENCE | ||||||
| 05/22/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: NEUROSCIENCE | ||||||
| 05/10/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $7.85 | General |
| Category: NEUROSCIENCE | ||||||
| 05/10/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.24 | General |
| Category: NEUROSCIENCE | ||||||
| 04/23/2024 | UCB, Inc. | Zilbrysq (Drug) | Food and Beverage | In-kind items and services | $12.39 | General |
| Category: Neurology | ||||||
| 04/23/2024 | UCB, Inc. | Zilbrysq (Drug) | Food and Beverage | In-kind items and services | $1.32 | General |
| Category: Neurology | ||||||
| 04/16/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Neurology | ||||||
| 04/13/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: NEUROSCIENCE | ||||||
| 03/24/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: NEUROSCIENCE | ||||||
| 03/11/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: Neurology | ||||||
| 03/04/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: NEUROSCIENCE | ||||||
| 03/04/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: Neurology | ||||||
| 03/03/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 183 | 277 | $54,430 | $30,457 |
| 2022 | 5 | 219 | 317 | $63,890 | $36,605 |
| 2021 | 4 | 175 | 261 | $52,660 | $31,709 |
| 2020 | 4 | 110 | 150 | $27,795 | $15,576 |
Total Patients
687
Total Services
1,005
Medicare Billing
$114,348
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 70 | 130 | $18,850 | $12,167 | 64.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 62 | 62 | $17,050 | $7,974 | 46.8% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 25 | 27 | $12,150 | $5,564 | 45.8% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 26 | 58 | $6,380 | $4,752 | 74.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 73 | 130 | $18,850 | $12,496 | 66.3% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2022 | 38 | 38 | $17,100 | $7,692 | 45.0% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 43 | 84 | $9,240 | $7,227 | 78.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 54 | 54 | $14,850 | $7,173 | 48.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 11 | 11 | $3,850 | $2,019 | 52.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 59 | 104 | $15,015 | $10,756 | 71.6% |
| 95912 | Nerve transmission studies, 11-12 studies | Office | 2021 | 39 | 41 | $18,450 | $8,931 | 48.4% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 38 | 77 | $8,470 | $6,868 | 81.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 39 | 39 | $10,725 | $5,154 | 48.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 49 | 70 | $9,800 | $6,026 | 61.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 31 | 31 | $8,525 | $3,965 | 46.5% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2020 | 18 | 37 | $4,070 | $3,064 | 75.3% |
| 95912 | Nerve transmission studies, 11-12 studies | Office | 2020 | 12 | 12 | $5,400 | $2,522 | 46.7% |
About Dr. Pei Liu, MD
Dr. Pei Liu, MD is a Clinical Neurophysiology healthcare provider based in Redlands, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/02/2014. The National Provider Identifier (NPI) number assigned to this provider is 1003234550.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Pei Liu, MD has received a total of $4,325 in payments from pharmaceutical and medical device companies, with $611.17 received in 2024. These payments were reported across 196 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($4,325).
As a Medicare-enrolled provider, Liu has provided services to 687 Medicare beneficiaries, totaling 1,005 services with total Medicare billing of $114,348. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Clinical Neurophysiology
- Other Specialties Neurology
- Location Redlands, CA
- Active Since 04/02/2014
- Last Updated 09/09/2022
- Taxonomy Code 2084N0600X
- Entity Type Individual
- NPI Number 1003234550
Products in Payments
- Briviact (Drug) $869.36
- UBRELVY (Drug) $701.76
- Aimovig (Biological) $350.42
- ULTOMIRIS (Biological) $331.60
- SOLIRIS (Drug) $164.08
- QULIPTA (Drug) $154.13
- BOTOX (Biological) $152.91
- VALTOCO (Drug) $152.33
- VNS Therapy (Device) $147.63
- AJOVY (Biological) $138.51
- TROKENDI XR (Drug) $123.19
- Soliris (Drug) $103.89
- TYSABRI (Biological) $80.73
- ONPATTRO (Drug) $79.08
- NURTEC ODT (Drug) $75.95
- Nayzilam (Drug) $74.62
- Rystiggo (Drug) $60.59
- APOKYN (Drug) $57.93
- AVONEX (Biological) $55.61
- Zilbrysq (Drug) $43.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.